Executive Interview – Heidelberg Pharma

Executive Interview – Heidelberg Pharma

Dr Jan Schmidt-Brand, CEO and CFO of Heidelberg discusses the group’s core technology and applications. In particular, he focuses on Heidelberg’s lead product HDP-101’s route to market and its advantages over the current standard of care and competitors such as CAR-T and ADCs.


You may also be interested in these:

Investment Companies

IP Group - executive interview

Investment Companies

Oakley Capital Investments – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free